Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Ravindra Majeti
Affiliation
Stanford University School of Medicine
ORCID
Career Start Year
1998
Papers
142
H Index
61
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36260702
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
Blood Adv
2023
38009738
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis.
J Vis Exp
2023
37704469
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).
Blood Rev
2023
37847741
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.
Blood Cancer Discov
2023
37790561
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML.
bioRxiv
2023
37581927
RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition.
J Clin Invest
2023
37986825
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity.
Res Sq
2023
37873452
Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia.
bioRxiv
2023
38091010
IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation.
Blood Cancer Discov
2023
36971438
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells.
J Vis Exp
2023
37067914
Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia.
Blood Cancer Discov
2023
36856575
Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy.
Cancer Discov
2023
36934059
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).
Blood Rev
2023
36897988
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint.
Proc Natl Acad Sci U S A
2023
36355448
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.
Cancer Discov
2023
35926108
Single-cell genomics in AML: extending the frontiers of AML research.
Blood
2023
35027753
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Nat Med
2022
35551192
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.
Nat Commun
2022
35840577
Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.
Nat Commun
2022
35763671
Reengineering Ponatinib to Minimize Cardiovascular Toxicity.
Cancer Res
2022
35532363
The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia.
Blood Cancer Discov
2022
35817829
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.
Nat Cancer
2022
36266326
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.
Leukemia
2022
36218325
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions.
Cancer Discov
2022
35177627
CytofIn enables integrated analysis of public mass cytometry datasets using generalized anchors.
Nat Commun
2022
35084991
Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells.
Annu Rev Med
2022
33473139
The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells.
Nat Commun
2021
33737751
Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells.
Nat Med
2021
34903734
Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia.
Nat Commun
2021
34407958
Clonal Hematopoiesis: From Mechanisms to Clinical Intervention.
Cancer Discov
2021
34778803
NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity.
Blood Cancer Discov
2021
34568834
Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia.
Blood Cancer Discov
2021
33473210
Restoring metabolism of myeloid cells reverses cognitive decline in ageing.
Nature
2021
32427583
Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapy.
JCI Insight
2020
31895700
Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2.
J Clin Invest
2020
32038992
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies.
Front Oncol
2020
31760071
The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.
J Hepatol
2020
33136125
CD34 expression does not correlate with immunophenotypic stem cell or progenitor content in human cord blood products.
Blood Adv
2020
33157042
Targeting LSCs: Peeling Back the Curtain on the Metabolic Complexities of AML.
Cell Stem Cell
2020
33123685
Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia.
Nat Cancer
2020
32150611
Single-cell mutational profiling enhances the clinical evaluation of AML MRD.
Blood Adv
2020
32114880
A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML.
Epigenetics
2020
32543932
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience.
Leuk Lymphoma
2020
32269167
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia.
Sci Transl Med
2020
30659850
Induced pluripotent stem cell modeling of malignant hematopoiesis.
Exp Hematol
2019
31874780
Use of polyvinyl alcohol for chimeric antigen receptor T-cell expansion.
Exp Hematol
2019
31727951
Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index.
Sci Rep
2019
32704085
Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells.
Gene Ther
2019
30811285
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.
J Clin Oncol
2019
30889374
No Matter How You Splice It, RBM39 Inhibition Targets Spliceosome Mutant AML.
Cancer Cell
2019
1 - 50 of 142
Column Actions
Search
Recommended Authors
Biniam Adane
The Broad Institute of MIT and Harvard
Career Start Year
2010
Number of shared co-authors
5
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2009
Number of shared co-authors
0
Jennifer Dunlap
Oregon Health & Science University
Career Start Year
2008
Number of shared co-authors
4
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year
2008
Number of shared co-authors
4
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year
2008
Number of shared co-authors
5
Brett M Stevens
University of Colorado School of Medicine
Career Start Year
2008
Number of shared co-authors
4
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2006
Number of shared co-authors
17
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year
2005
Number of shared co-authors
15
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year
2004
Number of shared co-authors
5
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year
2004
Number of shared co-authors
0
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year
2004
Number of shared co-authors
9
Tara L Lin
University of Kansas Medical Center
Career Start Year
2004
Number of shared co-authors
10
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year
2003
Number of shared co-authors
14
Sergei Doulatov
University of Washington
Career Start Year
2002
Number of shared co-authors
2
Phillip M Clair
Huntsman Cancer Institute, The University of Utah
Career Start Year
2001
Number of shared co-authors
3
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
7
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year
1998
Number of shared co-authors
0
Maura Gasparetto
University of Colorado School of Medicine
Career Start Year
1998
Number of shared co-authors
5
Kolja Eppert
McGill University
Career Start Year
1996
Number of shared co-authors
2
Brian J P Huntly
University of Cambridge
Career Start Year
1996
Number of shared co-authors
7
Yongjin Li
Mayo Clinic
Career Start Year
1995
Number of shared co-authors
7
Matthew J Walter
Washington University School of Medicine in St. Louis
Career Start Year
1994
Number of shared co-authors
9
Lucy A Godley
The University of Chicago
Career Start Year
1994
Number of shared co-authors
15
Timothy A Graubert
Massachusetts General Hospital
Career Start Year
1993
Number of shared co-authors
9
Michael Heuser
Hannover Medical School
Career Start Year
1993
Number of shared co-authors
12
Peter Westervelt
Washington University School of Medicine
Career Start Year
1990
Number of shared co-authors
8
Scott A Armstrong
Boston Children's Hospital
Career Start Year
1990
Number of shared co-authors
9
Guy Sauvageau
Universite de Montreal
Career Start Year
1988
Number of shared co-authors
1
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year
1987
Number of shared co-authors
5
John E Dick
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1980
Number of shared co-authors
6
row(s) 1 - 30 of 30
Collaborators
M Ryan Corces
Gladstone Institute of Neurological Disease
Co-authored papers
16
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Co-authored papers
12
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Co-authored papers
11
Yusuke Nakauchi
Institute of Space and Astronautical Science
Co-authored papers
8
Bruno C Medeiros
AbbVie Inc.
Co-authored papers
8
Arthur Weiss
University of California san francisco
Co-authored papers
7
Melissa Stafford
Ulster University
Co-authored papers
7
Howard Y Chang
Center for Personal Dynamic Regulomes, Stanford University
Co-authored papers
7
Matthew H Porteus
Stanford University
Co-authored papers
7
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Co-authored papers
6
Siddhartha Jaiswal
Co-authored papers
6
Jason Gotlib
Stanford University School of Medicine
Co-authored papers
4
Rafael Bejar
Moores Cancer Center, university of california san diego
Co-authored papers
4
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Co-authored papers
4
David P Steensma
Novartis Institutes for BioMedical Research
Co-authored papers
4
Christopher S Hourigan
and Blood Institute, National Institutes of Health
Co-authored papers
4
Katharina Schallmoser
Paracelsus Medical University
Co-authored papers
4
Michelle Monje
Co-authored papers
4
Uma Borate
The Ohio State University
Co-authored papers
4
Carolyn R Bertozzi
Stanford University
Co-authored papers
3
Jason D Buenrostro
Harvard University, Broad Institute of MIT and Harvard
Co-authored papers
3
Poul H Sorensen
British Columbia Cancer Research Centre
Co-authored papers
3
Rozario Thomas
Memorial Sloan Kettering Cancer Center (MSKCC)
Co-authored papers
2
Samuel H Cheshier
Co-authored papers
2
Dirk Strunk
Cell Therapy Institute, Paracelsus Medical University (PMU)
Co-authored papers
2
Anna L Brown
Adelaide Medical School, University of Adelaide
Co-authored papers
2
Julien Sage
Department of Pediatrics Stanford University Stanford California USA.
Co-authored papers
2
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers
2
Joshua D Rabinowitz
Lewis Sigler Institute for Integrative Genomics, Princeton University
Co-authored papers
2
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Co-authored papers
2
1 - 30